Cleared Traditional

K133642 - RAPIDFRET ORAL FLUID ASSAY FOR OPIATES; RAPIDFRET ORAL FLUID CALIBRATORS, CONTROLS, COLLECTOR; RAPIDFRET INTEGRATED WORK
(FDA 510(k) Clearance)

K133642 · Biophor Diagnostics, Inc. · Toxicology
Jan 2014
Decision
58d
Days
Class 2
Risk

K133642 is an FDA 510(k) clearance for the RAPIDFRET ORAL FLUID ASSAY FOR OPIATES; RAPIDFRET ORAL FLUID CALIBRATORS, CONTROLS, COLLECTOR; RAPIDFRET INTEGRATED WORK, a Enzyme Immunoassay, Opiates (Class II — Special Controls, product code DJG), submitted by Biophor Diagnostics, Inc. (Redwood City, US). The FDA issued a Cleared decision on January 24, 2014, 58 days after receiving the submission on November 27, 2013. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3650.

Submission Details

510(k) Number K133642 FDA.gov
FDA Decision Cleared SESE
Date Received November 27, 2013
Decision Date January 24, 2014
Days to Decision 58 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF

Device Classification

Product Code DJG — Enzyme Immunoassay, Opiates
Device Class Class II — Special Controls
CFR Regulation 21 CFR 862.3650

Similar Devices — DJG Enzyme Immunoassay, Opiates

All 214
Labcorp Fentanyl Urine Visual Test
K252684 · Medtox Diagnostics, Inc. · Jan 2026
Evidence MultiSTAT DOA Urine MultiPlex
K250741 · Randox Laboratories Limited · Jan 2026
LZI Buprenorphine II Enzyme Immunoassay
K253082 · Lin-Zhi International, Inc. · Jan 2026
SEFRIA? Hydrocodone Oral Fluid
K252520 · Immunalysis Corporation · Sep 2025
Healgen? AccuFluor Fentanyl Fluorescence Immunoassay (FIA)Test Kit - Qualitative; Healgen? Immunofluorescence Analyzer (OG-H180)
K251972 · Healgen Scientific, LLC · Aug 2025
LZI Fentanyl III Enzyme Immunoassay
K251634 · Lin-Zhi International, Inc. · Jun 2025